Detalles de la búsqueda
1.
Cost-effectiveness of intensification with sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom.
Diabetes Obes Metab
; 21(4): 1010-1017, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565386
2.
Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
Cardiovasc Drugs Ther
; 26(2): 167-79, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22418856
3.
Cost-effectiveness of intensification with SGLT2 inhibitors for type 2 diabetes.
Am J Manag Care
; 27(8): e269-e277, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460181
4.
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin.
Pharmacoeconomics
; 39(3): 317-330, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150566
5.
Projected cost-effectiveness of ezetimibe/simvastatin compared with doubling the statin dose in the United Kingdom: findings from the INFORCE study.
Value Health
; 13(6): 726-34, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20561328
6.
Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes.
Am J Manag Care
; 25(5): 231-238, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120717
7.
Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
Clin Res Cardiol
; 108(5): 487-509, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30302558
8.
Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis.
Diabetes Ther
; 10(2): 473-491, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689140
9.
Use and impact of the prehospital 12-lead ECG in the primary PCI era (PHECG2): protocol for a mixed-method study.
Open Heart
; 6(2): e001156, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31803487
10.
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Eur J Cancer
; 43(2): 299-307, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17134890
11.
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.
Clin Ther
; 29(5): 778-794, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17697899
12.
State transition model: vorapaxar added to standard antiplatelet therapy to prevent thrombosis post myocardial infarction or peripheral artery disease.
Curr Med Res Opin
; 33(9): 1535-1543, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28277861
13.
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States.
J Med Econ
; 20(7): 723-731, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426345
14.
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circ Cardiovasc Qual Outcomes
; 10(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28506979
15.
A State Transition Model for Health Outcomes Associated with Vorapaxar Treatment as an Add-on to Standard Care Antiplatelet Therapy in the Prevention of Thrombotic Events for Patients with a Recent Myocardial Infarction.
Am J Cardiovasc Drugs
; 16(4): 285-295, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262432
16.
Projected coronary heart disease risk benefit with ezetimibe.
Atherosclerosis
; 179(2): 375-8, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15777556
17.
Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
Curr Med Res Opin
; 21(9): 1389-99, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16197657
18.
Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal.
J Med Econ
; 18(8): 565-72, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25788039
19.
The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
Clin Ther
; 26(11): 1895-904, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15639701
20.
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.
Pharmacoeconomics
; 22 Suppl 3: 49-61, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15669153